203 publications
Evolocumab (Repatha®) for the treatment of hypercholeresterolaemia
Zorginstituut Nederland issued package advice on the medicinal product evolocumab (Repatha®) for the treatment of...
Cysteamine eyedrops (Cystadrops®) for the treatment of cystinosis
Zorginstituut Nederland carried out an assessment of the medicinal product cysteamine (Cystadrops®). The viscous cysteamine HCL...
Room for improvement analysis: Chest pain (Suspected) Stable Angina Pectoris - Zinnige Zorg
Zorginstituut Nederland’s motto is "Taking care of good health care: no more and no less than necessary". Every citizen must be...
Idebenone (Raxone®) for the treatment of Leber’s Hereditary Optic Neuropathy (LHON)
Zorginstituut Nederland has carried out an assessment of the medicinal product idebenone (Raxone®). Idebenone (Raxone®) is not...
Programme ‘Outcome Information for Shared Decision-Making’ - factsheet
Project: ‘ICHOM as an accelerator for outcome information’ - factsheet
Glycerol phenylbutyrate (Ravicti®) for the treatment of urea-cycle disorders
Zorginstituut Nederland has carried out an assessment of the medicinal product glycerol phenylbutyrate (Ravicti®) for the...
Cetuximab (Erbitux®) for the treatment of metastatic colorectal cancer
Zorginstituut Nederland has carried out a re-assessment of the medicinal product cetuximab (Erbitux®), whereby they came to the...
Acarizax® in cases of allergic rhinitis due to house dust mite
Zorginstituut Nederland carried out an assessment of whether the medicinal product Acarizax® is interchangeable with a drug...
A paradigm shift in perception, learning and action - core of the second advice of the Committee Innovation Health Care Professions & Education
Translation of the core of the second advice of The Committee Innovation Health Care Professions & Education.